Jing Su
Shandong University
8 Papers
74 Citations
Jing Su is an academic researcher from Shandong University. The author has contributed to research in topics: Luciferase & MAPK/ERK pathway. The author has an hindex of 6, co-authored 8 publications. Previous affiliations of Jing Su include Protein Sciences & Qilu University of Technology.
Chat about Author
Papers
Different downstream signalling of CCK1 receptors regulates distinct functions of CCK in pancreatic beta cells
Shanglei Ning,Shanglei Ning,Wenshuai Zheng,Wenshuai Zheng,Jing Su,Jing Su,Nan Liang,Nan Liang,Hui Li,Hui Li,Dao-lai Zhang,Dao-lai Zhang,Chun-Hua Liu,Chun-Hua Liu,Jun-hong Dong,Jun-hong Dong,Zheng-kui Zhang,Min Cui,Qiao-Xia Hu,Qiao-Xia Hu,Chao-chao Chen,Chao-chao Chen,Chang-hong Liu,Chuan Wang,Qi Pang,Yuxin Chen,Xiao Yu,Jin-Peng Sun +27 more
TL;DR: In this paper, the sulfated carboxy-terminal octapeptide CCK26-33 amide (CCK-8s) activated CCK1 receptors and induced accumulation of both IP3 and cAMP.
47
Calcium influx activates adenylyl cyclase 8 for sustained insulin secretion in rat pancreatic beta cells
Haiqiang Dou,Changhe Wang,Xi Wu,Lijun Yao,Xiaoyu Zhang,Sasa Teng,Huadong Xu,Bin Liu,Qihui Wu,Quanfeng Zhang,Meiqin Hu,Yeshi Wang,Li Wang,Yi Wu,Shujiang Shang,Xinjiang Kang,Lianghong Zheng,Jin Zhang,Matthieu Raoux,Jochen Lang,Qing Li,Jing Su,Xiao Yu,Liangyi Chen,Zhuan Zhou +24 more
TL;DR: These findings suggest that depolarisation-induced Ca2+ influx plays dual roles in regulating exocytosis in rat pancreatic beta cells by triggering vesicle fusion and replenishing the vesicles pool to support sustained insulin release.
Inhibiting Firefly Bioluminescence by Chalcones.
Huateng Zhang,Jing Su,Yuxin Lin,Haixiu Bai,Jiaxiang Liu,Hui Chen,Lupei Du,Lichuan Gu,Minyong Li +8 more
TL;DR: This research discovered a series of chalcone compounds as Fluc inhibitors with favorable potency both in vitro and in vivo and demonstrated that compound 3i is competitive for substrate aminoluciferin, while noncompetitive for ATP.
16
Engineered Thermoplasma acidophilum factor F3 mimics human aminopeptidase N (APN) as a target for anticancer drug development.
Jing Su,Qiang Wang,Qiang Wang,Jinhong Feng,Cong Zhang,Deyu Zhu,Tiandi Wei,Wenfang Xu,Lichuan Gu +8 more
TL;DR: It is proposed here now that engineered factor F3 can be employed as a reasonable alternative of hAPN for drug design and development and discloses that compound D24 targetting the structure of E. coli APN cannot bind to the activity cleft offactor F3 with high affinity.
8
Aminoluciferin 4-hydroxyphenyl amide enables bioluminescence detection of endogenous tyrosinase
Chunchao Tang,Lei Jin,Yuxing Lin,Jing Su,Yingai Sun,Pan Liu,Qi Li,Guankai Wang,Zheng Zhang,Lupei Du,Minyong Li +10 more
TL;DR: TyrBP-3 is the first bioluminescent probe that can image tyrosinase on a cellular level and can also visualize the level of tyosinase activity in tumors of living animals, and it is anticipated that Tyr BP-3 can be a good tool to monitor tyros in complex biosystems in the future.
5